Published on
Mar 21, 2025
Clinical Practice Evidence of Treatment Satisfaction with Moderate and High-Efficacy Drugs in Multiple Sclerosis
Introduction Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease that affects the central nervous system (CNS), causing demyelination and neuronal injury. MS is the most common cause of non-traumatic disability among individual aged 18 …
Source:
Dove Medical Press
-
Neutral
